Detalles de la búsqueda
1.
Transfer transcriptomic signatures for infectious diseases
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20203406
2.
Predicting the mutational drivers of future SARS-CoV-2 variants of concern
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259286
3.
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474380
4.
Antibody therapy reverses biological signatures of COVID-19 progression
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268197
5.
Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-438258
6.
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-023903
7.
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-484787
8.
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-464254
9.
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-437925
10.
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-426475
11.
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-102038
12.
Robust and durable prophylactic protection conferred by RNA interference in preclinical models of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-485044
13.
Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249840
14.
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-509852
15.
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-442808
16.
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-434607
17.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-472269
18.
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-438709
19.
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-438818
20.
The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-355842
Resultados
1 -
20
de 20
1
Próxima >
>>